Cargando…

Percutaneous irreversible electroporation for breast tissue and breast cancer: safety, feasibility, skin effects and radiologic–pathologic correlation in an animal study

BACKGROUND: To study the safety, feasibility and skin effects of irreversible electroporation (IRE) for breast tissue and breast cancer in animal models. METHODS: Eight pigs were used in this study. IRE was performed on the left breasts of the pigs with different skin–electrode distances, and the ri...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Sheng, Chen, Fei, Shen, Lujun, Zeng, Qi, Wu, Peihong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975887/
https://www.ncbi.nlm.nih.gov/pubmed/27495906
http://dx.doi.org/10.1186/s12967-016-0993-7
_version_ 1782446792552480768
author Li, Sheng
Chen, Fei
Shen, Lujun
Zeng, Qi
Wu, Peihong
author_facet Li, Sheng
Chen, Fei
Shen, Lujun
Zeng, Qi
Wu, Peihong
author_sort Li, Sheng
collection PubMed
description BACKGROUND: To study the safety, feasibility and skin effects of irreversible electroporation (IRE) for breast tissue and breast cancer in animal models. METHODS: Eight pigs were used in this study. IRE was performed on the left breasts of the pigs with different skin–electrode distances, and the right breasts were used as controls. The electrodes were placed 1–8 mm away from the skin, with an electrode spacing of 1.5–2 cm. Imaging and pathological examinations were performed at specific time points for follow-up evaluation. Vital signs, skin damage, breast tissue changes and ablation efficacy were also closely observed. Eight rabbit models with or without VX2 breast tumor implantations were used to further assess the damage caused by and the repair of thin skin after IRE treatment for breast cancer. Contrast-enhanced ultrasound and elastosonography were used to investigate ablation efficacy and safety. RESULTS: During IRE, the color of the pig breast skin reversibly changed. When the skin–electrode distance was 3 mm, the breast skin clearly changed, becoming white in the center and purple in the surrounding region during IRE. One small purulent skin lesion was detected several days after IRE. When the skin–electrode distance was 5–8 mm, the breast skin became red during IRE. However, the skin architecture was normal when evaluated using gross pathology and hematoxylin-eosin staining. When the skin–electrode distance was 1 mm, skin atrophy and yellow glabrescence occurred in the rabbit breasts after IRE. When the skin–electrode distance was ≥5 mm, there was no skin damage in the rabbit model regardless of breast cancer implantation. After IRE, complete ablation of the targeted breast tissue or cancer was confirmed, and apoptosis was detected in the target tissue and outermost epidermal layer. In the ablated breasts of the surviving animals, complete mammary regeneration with normal skin and hair was observed. Furthermore, no massive fibrosis or mass formation were detected on ultrasound or through hematoxylin–eosin staining. CONCLUSIONS: After IRE, the skin architecture was well preserved when the skin–electrode distance was ≥5 mm. Moreover, breast regeneration occurred without mass formation or obvious fibrosis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12967-016-0993-7) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4975887
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49758872016-08-07 Percutaneous irreversible electroporation for breast tissue and breast cancer: safety, feasibility, skin effects and radiologic–pathologic correlation in an animal study Li, Sheng Chen, Fei Shen, Lujun Zeng, Qi Wu, Peihong J Transl Med Research BACKGROUND: To study the safety, feasibility and skin effects of irreversible electroporation (IRE) for breast tissue and breast cancer in animal models. METHODS: Eight pigs were used in this study. IRE was performed on the left breasts of the pigs with different skin–electrode distances, and the right breasts were used as controls. The electrodes were placed 1–8 mm away from the skin, with an electrode spacing of 1.5–2 cm. Imaging and pathological examinations were performed at specific time points for follow-up evaluation. Vital signs, skin damage, breast tissue changes and ablation efficacy were also closely observed. Eight rabbit models with or without VX2 breast tumor implantations were used to further assess the damage caused by and the repair of thin skin after IRE treatment for breast cancer. Contrast-enhanced ultrasound and elastosonography were used to investigate ablation efficacy and safety. RESULTS: During IRE, the color of the pig breast skin reversibly changed. When the skin–electrode distance was 3 mm, the breast skin clearly changed, becoming white in the center and purple in the surrounding region during IRE. One small purulent skin lesion was detected several days after IRE. When the skin–electrode distance was 5–8 mm, the breast skin became red during IRE. However, the skin architecture was normal when evaluated using gross pathology and hematoxylin-eosin staining. When the skin–electrode distance was 1 mm, skin atrophy and yellow glabrescence occurred in the rabbit breasts after IRE. When the skin–electrode distance was ≥5 mm, there was no skin damage in the rabbit model regardless of breast cancer implantation. After IRE, complete ablation of the targeted breast tissue or cancer was confirmed, and apoptosis was detected in the target tissue and outermost epidermal layer. In the ablated breasts of the surviving animals, complete mammary regeneration with normal skin and hair was observed. Furthermore, no massive fibrosis or mass formation were detected on ultrasound or through hematoxylin–eosin staining. CONCLUSIONS: After IRE, the skin architecture was well preserved when the skin–electrode distance was ≥5 mm. Moreover, breast regeneration occurred without mass formation or obvious fibrosis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12967-016-0993-7) contains supplementary material, which is available to authorized users. BioMed Central 2016-08-05 /pmc/articles/PMC4975887/ /pubmed/27495906 http://dx.doi.org/10.1186/s12967-016-0993-7 Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Li, Sheng
Chen, Fei
Shen, Lujun
Zeng, Qi
Wu, Peihong
Percutaneous irreversible electroporation for breast tissue and breast cancer: safety, feasibility, skin effects and radiologic–pathologic correlation in an animal study
title Percutaneous irreversible electroporation for breast tissue and breast cancer: safety, feasibility, skin effects and radiologic–pathologic correlation in an animal study
title_full Percutaneous irreversible electroporation for breast tissue and breast cancer: safety, feasibility, skin effects and radiologic–pathologic correlation in an animal study
title_fullStr Percutaneous irreversible electroporation for breast tissue and breast cancer: safety, feasibility, skin effects and radiologic–pathologic correlation in an animal study
title_full_unstemmed Percutaneous irreversible electroporation for breast tissue and breast cancer: safety, feasibility, skin effects and radiologic–pathologic correlation in an animal study
title_short Percutaneous irreversible electroporation for breast tissue and breast cancer: safety, feasibility, skin effects and radiologic–pathologic correlation in an animal study
title_sort percutaneous irreversible electroporation for breast tissue and breast cancer: safety, feasibility, skin effects and radiologic–pathologic correlation in an animal study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975887/
https://www.ncbi.nlm.nih.gov/pubmed/27495906
http://dx.doi.org/10.1186/s12967-016-0993-7
work_keys_str_mv AT lisheng percutaneousirreversibleelectroporationforbreasttissueandbreastcancersafetyfeasibilityskineffectsandradiologicpathologiccorrelationinananimalstudy
AT chenfei percutaneousirreversibleelectroporationforbreasttissueandbreastcancersafetyfeasibilityskineffectsandradiologicpathologiccorrelationinananimalstudy
AT shenlujun percutaneousirreversibleelectroporationforbreasttissueandbreastcancersafetyfeasibilityskineffectsandradiologicpathologiccorrelationinananimalstudy
AT zengqi percutaneousirreversibleelectroporationforbreasttissueandbreastcancersafetyfeasibilityskineffectsandradiologicpathologiccorrelationinananimalstudy
AT wupeihong percutaneousirreversibleelectroporationforbreasttissueandbreastcancersafetyfeasibilityskineffectsandradiologicpathologiccorrelationinananimalstudy